title: A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis.
abstract: Venous thromboembolism is a serious complication following gynecologic surgery and is particularly common in patients with malignancy. A previous study of subcutaneous low-dose heparin given as one dose preoperatively and every 12 hours postoperatively failed to show a benefit in gynecologic oncology patients. In the present study, two more intense regimens of low-dose heparin were evaluated. Three hundred four patients were assigned randomly to receive no prophylaxis (controls), subcutaneous heparin 5000 units 2 hours before surgery and every 8 hours postoperatively (low-dose heparin) (regimen I), or 5000 units heparin subcutaneously every 8 hours preoperatively (between two and nine doses) and every 8 hours postoperatively (regimen II). All patients had thromboembolism surveillance with the fibrinogen uptake test and clinical evaluation. Eighty-four percent had a malignancy. Thromboemboli were diagnosed in 19 of 103 control patients, ten of 104 regimen I patients, and six of 97 regimen II patients, a statistically significant difference (P less than .008). When compared with the control group, the study groups had no evidence of increased bleeding complications or alteration of laboratory coagulation indicators.
authors.affiliation: Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina.
authors.forename: D L
authors.initials: DL
authors.lastname: Clark-Pearson
authors.forename: E
authors.initials: E
authors.lastname: DeLong
authors.forename: I S
authors.initials: IS
authors.lastname: Synan
authors.forename: J T
authors.initials: JT
authors.lastname: Soper
authors.forename: W T
authors.initials: WT
authors.lastname: Creasman
authors.forename: R E
authors.initials: RE
authors.lastname: Coleman
mesh_terms: D005260:Female; D005340:Fibrinogen; D005833:Genital Neoplasms, Female / Q000601:surgery; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007457:Iodine Radioisotopes; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D013924:Thrombophlebitis / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*
chemical_list: D007457:Iodine Radioisotopes; D005340:Fibrinogen; D006493:Heparin